ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

INBX Inhibrx Inc

34.15
0.14 (0.41%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Inhibrx Inc INBX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.14 0.41% 34.15 06:22:21
개장가 저가 고가 종가 전일 종가
34.35 33.87 34.45 34.15 34.01
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/03/202405:26EDGAR2Form 144 - Report of proposed sale of securities
09/03/202406:08EDGAR2Form 144 - Report of proposed sale of securities
09/03/202405:28EDGAR2Form 144 - Report of proposed sale of securities
07/03/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202404:58EDGAR2Form 144 - Report of proposed sale of securities
05/03/202408:26EDGAR2Form 144 - Report of proposed sale of securities
01/03/202407:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
28/02/202423:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
28/02/202423:12EDGAR2Form 8-K - Current report
28/02/202423:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/02/202406:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202406:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/01/202402:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
24/01/202407:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/01/202420:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/01/202420:35EDGAR2Form 8-K - Current report
23/01/202420:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/01/202419:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/01/202415:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
10/11/202306:03EDGAR2Form 8-K - Current report
10/11/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
02/11/202322:16EDGAR2Form 8-K - Current report
02/11/202322:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
19/10/202305:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
20/09/202305:03EDGAR2Form 8-K - Current report
20/09/202305:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
01/09/202305:06EDGAR2Form D - Notice of Exempt Offering of Securities
29/08/202322:03EDGAR2Form 8-K - Current report
29/08/202322:00PRNUSInhibrx Announces $200 Million Private Placement Financing
08/08/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
30/05/202322:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
30/05/202322:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
09/05/202305:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock